Another week has come and gone as the second term of President Donald Trump approaches the six-month mark The past week ...

As public health insurance in the United States faces potential cuts, a Rutgers University review of medical records finds ...

One key unsettled issue stalling progress on President Donald Trump’s big bill in Congress is particularly daunting: How to ...

The nation’s major health insurers are promising to scale back and improve a widely despised practice that leads to care delays and complications.

By upholding Tennessee's law banning trans healthcare for kids, the Supreme Court rules for common sense and prevents irreversible decisions.

United Healthcare: Profitability at an Attractive Valuation One of the most dramatic reactions from the Q1 2025 earnings season came from United Healthcare (NYSE:UNH), which shed over $200 billion ...

FDA chief Marty Makary just committed to me to do a full review of the chemical abortion drug’s safety: “As Commissioner of Food and Drugs, I am committed to conducting a review of ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

Returning CEO of Eden Prairie-based health care giant didn't address coverage denials, an issue raised by a shareholder with regard to AI technology ...

UnitedHealth Group investors, stunned by missteps at the once predictable healthcare giant, are warily expecting strategic changes in its Medicare Advantage health insurance business over the next ...

Medicare Advantage review methodology The Medicare Advantage marketplace is concentrated among just a handful of companies; in many places, one insurer serves more than half of the market ...